We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0LB2 Supernus Pharmaceuticals Inc

0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes

Supernus Pharmaceuticals Financial Summary

The current 0LB2 market cap is 3B. The company's latest EPS is USD 0.0241 and P/E is 1220.75.

Year End 31 December 2023 20192020202120222023
Total Revenue 392.76M520.4M586.31M667.75M609.04M
Operating Income 148.57M173.7M86.03M46.12M-5.27M
Net Income 113.06M126.95M53.42M60.71M1.32M
Year End 31 December 2023 20192020202120222023
Total Assets 1.16B1.5B1.69B1.7B1.28B
Total Liabilities 564.85M759.24M873.3M816.3M356.16M
Total Equity 595.43M744.86M815.85M886.2M921.52M

Cash Flow

Year End 31 December 2023 20192020202120222023
Operating 143.13M138.4M127.13M116.83M111.09M
Investing -157.92M-34.7M-81.91M-216.66M268.73M
Financing 3.93M3.56M-130.42M-10.48M-397.88M
Market Cap 3B
Price to Earnings Ratio 1220.75
Price to Sales Ratio 2.64
Price to Cash Ratio 21.42
Price to Book Ratio 1.74
Dividend Yield -

Share Statistics

Shares Outstanding 54.63M
Average Volume (1 week) 101
Average Volume (1 Month) 92
52 Week Change 0.00%
52 Week High 55.00
52 Week Low 55.00
Spread (Intraday) 0 (0%)

Company Info

Company Name Supernus Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock